COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - EPA:CRI - FR0000130692 - Common Stock
10.72 EUR
+0.42 (+4.08%)
CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 16 industry peers in the Industrial Conglomerates industry. CRI has a bad profitability rating. Also its financial health evaluation is rather negative. CRI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
CRI had a positive operating cash flow in the past year.
CRI had positive earnings in 4 of the past 5 years.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
CRI has a Return On Assets of 0.26%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
Looking at the Return On Equity, with a value of 0.96%, CRI is doing worse than 68.75% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.19%, CRI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRI is in line with the industry average of 6.11%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROIC | 5.19% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
With a Profit Margin value of 0.34%, CRI is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of CRI has declined.
CRI has a Operating Margin (6.46%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
With a Gross Margin value of 28.51%, CRI is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRI is destroying value.
The number of shares outstanding for CRI has been increased compared to 1 year ago.
CRI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.24, we must say that CRI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRI (1.24) is worse than 87.50% of its industry peers.
The Debt to FCF ratio of CRI is 131.84, which is on the high side as it means it would take CRI, 131.84 years of fcf income to pay off all of its debts.
CRI's Debt to FCF ratio of 131.84 is on the low side compared to the rest of the industry. CRI is outperformed by 62.50% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
The Debt to Equity ratio of CRI (1.38) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.84
WACC6.19%
2.3 Liquidity
CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
CRI has a worse Current ratio (1.30) than 81.25% of its industry peers.
A Quick Ratio of 0.86 indicates that CRI may have some problems paying its short term obligations.
CRI has a worse Quick ratio (0.86) than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 146.24%, which is quite impressive.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
The Revenue has been growing slightly by 6.67% in the past year.
Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 40.14% on average per year.
CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y46.67%
EPS Next 2Y46.23%
EPS Next 3Y40.14%
EPS Next 5YN/A
Revenue Next Year5.01%
Revenue Next 2Y5.88%
Revenue Next 3Y4.86%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 89.33 indicates a quite expensive valuation of CRI.
68.75% of the companies in the same industry are cheaper than CRI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CRI to the average of the S&P500 Index (27.53), we can say CRI is valued expensively.
CRI is valuated reasonably with a Price/Forward Earnings ratio of 11.35.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.04. CRI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.33 | ||
| Fwd PE | 11.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CRI is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 62.50% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83.38 | ||
| EV/EBITDA | 7.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CRI's earnings are expected to grow with 40.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.91
PEG (5Y)N/A
EPS Next 2Y46.23%
EPS Next 3Y40.14%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.26%.
Compared to an average industry Dividend Yield of 13.17, CRI's dividend is way lower than its industry peers. On top of this 81.25% of the companies listed in the same industry pay a better dividend than CRI!
Compared to an average S&P500 Dividend Yield of 2.40, CRI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CRI pays out 128.00% of its income as dividend. This is not a sustainable payout ratio.
DP128%
EPS Next 2Y46.23%
EPS Next 3Y40.14%
EPA:CRI (10/16/2025, 5:25:11 PM)
10.72
+0.42 (+4.08%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap266.82M
Analysts75
Price Target13.09 (22.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP128%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.85%
PT rev (3m)-4.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.1%
EPS NY rev (3m)-40.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.33 | ||
| Fwd PE | 11.35 | ||
| P/S | 0.37 | ||
| P/FCF | 83.38 | ||
| P/OCF | 11.4 | ||
| P/B | 1.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.29 |
EPS(TTM)0.12
EY1.12%
EPS(NY)0.94
Fwd EY8.81%
FCF(TTM)0.13
FCFY1.2%
OCF(TTM)0.94
OCFY8.77%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)1.91
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROCE | 7.08% | ||
| ROIC | 5.19% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 13.23% | ||
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% | ||
| FCFM | 0.44% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Debt/EBITDA | 4.62 | ||
| Cap/Depr | 65.16% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30% | ||
| Profit Quality | 128% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.24 |
F-Score7
WACC6.19%
ROIC/WACC0.84
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y46.67%
EPS Next 2Y46.23%
EPS Next 3Y40.14%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year5.01%
Revenue Next 2Y5.88%
Revenue Next 3Y4.86%
Revenue Next 5YN/A
EBIT growth 1Y57.72%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year118.91%
EBIT Next 3Y41.15%
EBIT Next 5YN/A
FCF growth 1Y109.04%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y241.82%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%